VIZIRGIANAKIS STAVROS G. purchased 63.2% of their position (2.26M shares) of XTANT MEDICAL HOLDINGS, INC. on the open market
Open‑market purchase worth $1.09M — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 10/11/2022ACC: 0001235802-22-000113
Director
Since Aug 2022
+2.83M
Net shares
Net buyer
$1.09M
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
2.83M acquired
Non-Derivative Transactions1
Common Stock, $0.000001 par value
Direct
Shares
+2.26M
Price / share
$0.48
Trade value
$1.09M
% of position
63.2%
10/7/2022
3.59M→5.85M
Total
Net shares
+2.26M
Net value
$1.09M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.000001 par value Direct | 10/7/2022 | P · Purchase | +2.26M | $0.48 | $1.09M | 63.2% | 3.59M | 5.85M |
| Total | +2.26M | $1.09M | ||||||
Derivative Transactions1
Warrant
Direct
Converts to
Common Stock
566.21K shares
Shares
+566.21K
Strike price
0.48
Held after
566.21K
Exercisable
—
10/7/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrant Direct | Common Stock566.21K shares | 10/7/2022 | P · Purchase | +566.21K | 0.48 | — | 566.21K |